These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6599696)

  • 41. Substance P in human essential hypertension.
    Faulhaber HD; Oehme P; Baumann R; Enderlein J; Rathsack R; Rostock G; Naumann E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S172-6. PubMed ID: 2455174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased platelet size and release reaction in essential hypertension.
    Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
    J Hypertens; 1987 Aug; 5(4):401-6. PubMed ID: 2959720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension.
    Weidmann P
    Clin Exp Hypertens A; 1989; 11 Suppl 1():257-73. PubMed ID: 2663249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
    Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
    Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythrocyte membrane calcium binding in normotensive and hypertensive subjects.
    Bing RF; Booth GC; Heagerty AM; Swales JD
    J Hypertens Suppl; 1986 Dec; 4(6):S299-302. PubMed ID: 3475417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma norepinephrine variation with dietary sodium intake in normotensive subjects and patients with essential hypertension].
    Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
    Nihon Naibunpi Gakkai Zasshi; 1982 Sep; 58(9):1055-66. PubMed ID: 7173454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Hypertension; 1998 Jul; 32(1):96-100. PubMed ID: 9674644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Norepinephrine-related mechanism in hypertension accompanying renal failure.
    Schohn D; Weidmann P; Jahn H; Beretta-Piccoli C
    Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of sodium supplementation during energy restriction on plasma norepinephrine levels in obese women.
    Gougeon R; Mitchell TH; Larivière F; Abraham G; Montambault M; Marliss EB
    J Clin Endocrinol Metab; 1991 Nov; 73(5):975-81. PubMed ID: 1939535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated total body noradrenaline spillover in normotensive members of hypertensive families.
    Ferrier C; Cox H; Esler M
    Clin Sci (Lond); 1993 Feb; 84(2):225-30. PubMed ID: 8382587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autonomic abnormalities demonstrable in young normotensive subjects who are children of hypertensive parents.
    Lopes HF; Silva HB; Consolim-Colombo FM; Barreto Filho JA; Riccio GM; Giorgi DM; Krieger EM
    Braz J Med Biol Res; 2000 Jan; 33(1):51-4. PubMed ID: 10625874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet activity, prostacycline metabolite, plasma lipids and sympathoadrenal activity in patients with borderline hypertension and a positive family history of hypertension.
    Wocial B; Januszewicz W; Bar-Andziak E; Grzesiuk W; Kuczyńska K; Berent H; Ignatowska-Switalska H; Kapiński M; Młyński J
    Cor Vasa; 1990; 32(4):265-73. PubMed ID: 2146090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adrenomedullary secretion of epinephrine is increased in mild essential hypertension.
    Jacobs MC; Lenders JW; Willemsen JJ; Thien T
    Hypertension; 1997 Jun; 29(6):1303-8. PubMed ID: 9180633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 86Rubidium uptake in mononuclear leucocytes from young subjects at increased risk of developing essential hypertension.
    Nielsen JR; Johansen T; Pedersen KE; Klitgaard NA
    J Hypertens; 1988 Oct; 6(10):815-9. PubMed ID: 2848886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of verapamil in essential hypertension.
    Städler P; Leonardi L; Riesen W; Ziegler W; Marone C; Beretta-Piccoli C
    Clin Pharmacol Ther; 1987 Nov; 42(5):485-92. PubMed ID: 3315389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of epinephrine on norepinephrine release in essential hypertension.
    Nezu M; Miura Y; Adachi M; Adachi M; Kimura S; Toriyabe S; Ishizuka Y; Ohashi H; Sugawara T; Takahashi M
    Hypertension; 1985; 7(2):187-95. PubMed ID: 3980065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of digoxin on the vascular reactivity to infused norepinephrine in normotensive subjects.
    Fujii H
    Hiroshima J Med Sci; 1987 Jun; 36(2):233-44. PubMed ID: 2820905
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiovascular regulation during administration of co-dergocrine to normal subjects.
    Gerber A; Weidmann P; Laederach K
    Eur J Clin Pharmacol; 1986; 29(5):565-72. PubMed ID: 3956562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Am J Hypertens; 1996 Aug; 9(8):739-45. PubMed ID: 8862219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension.
    Sowers JR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1133-7. PubMed ID: 7298797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.